1. Amundsen SS, Rundberg J, Adamovic S, Gudjónsdóttir AH, Ascher H, Ek J, Nilsson S, Lie BA, Naluai AT, Sollid LM. (2010) Four novel coeliac disease regions replicated in an association study of a Swedish-Norwegian family cohort.
Genes Immun, 11 (1): 79-86.
[PMID:19693089]
2. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C et al.. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
Nat Genet, 41 (6): 703-7.
[PMID:19430480]
3. Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, Butcher EC. (1998) Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members.
J Biol Chem, 273 (43): 28040-8.
[PMID:9774420]
4. Bradfield JP, Qu HQ, Wang K, Zhang H, Sleiman PM, Kim CE, Mentch FD, Qiu H, Glessner JT, Thomas KA et al.. (2011) A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
PLoS Genet, 7 (9): e1002293.
[PMID:21980299]
5. Caballero-Franco C, Kissler S. (2016) The autoimmunity-associated gene RGS1 affects the frequency of T follicular helper cells.
Genes Immun, 17 (4): 228-38.
[PMID:27029527]
6. Denecke B, Meyerdierks A, Böttger EC. (1999) RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors.
J Biol Chem, 274 (38): 26860-8.
[PMID:10480894]
7. Desai BB, Albright JW, Albright JF. (1987) Cooperative action of complement component C3 and phagocytic effector cells in innate murine resistance to Trypanosoma lewisi.
Infect Immun, 55 (2): 358-63.
[PMID:3026965]
8. Gibbons DL, Abeler-Dörner L, Raine T, Hwang IY, Jandke A, Wencker M, Deban L, Rudd CE, Irving PM, Kehrl JH et al.. (2011) Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential.
J Immunol, 187 (5): 2067-71.
[PMID:21795595]
9. Guo CC, Wang M, Cao FD, Huang WH, Xiao D, Ye XG, Ou ML, Zhang N, Zhang BH, Liu Y et al.. (2016) Meta-Analysis on Associations of RGS1 and IL12A Polymorphisms with Celiac Disease Risk.
Int J Mol Sci, 17 (4).
[PMID:27043536]
10. Han SB, Moratz C, Huang NN, Kelsall B, Cho H, Shi CS, Schwartz O, Kehrl JH. (2005) Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles.
Immunity, 22 (3): 343-54.
[PMID:15780991]
11. Heximer SP, Cristillo AD, Forsdyke DR. (1997) Comparison of mRNA expression of two regulators of G-protein signaling, RGS1/BL34/1R20 and RGS2/G0S8, in cultured human blood mononuclear cells.
DNA Cell Biol, 16 (5): 589-98.
[PMID:9174164]
12. Hong JX, Wilson GL, Fox CH, Kehrl JH. (1993) Isolation and characterization of a novel B cell activation gene.
J Immunol, 150 (9): 3895-904.
[PMID:8473738]
13. Hu X, Tang J, Zeng G, Hu X, Bao P, Wu J, Liang Y, Deng W, Tang Y. (2019) RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll-like receptor signaling pathway.
J Cell Physiol, 234 (11): 20432-20442.
[PMID:31012109]
14. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D et al.. (2008) Newly identified genetic risk variants for celiac disease related to the immune response.
Nat Genet, 40 (4): 395-402.
[PMID:18311140]
15. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z et al.. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Nature, 476 (7359): 214-9.
[PMID:21833088]
16. International Multiple Sclerosis Genetics Conssortium (IMSGC). (2010) IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.
Genes Immun, 11 (5): 397-405.
[PMID:20555355]
17. Izzo V, Pinelli M, Tinto N, Esposito MV, Cola A, Sperandeo MP, Tucci F, Cocozza S, Greco L, Sacchetti L. (2011) Improving the estimation of celiac disease sibling risk by non-HLA genes.
PLoS ONE, 6 (11): e26920.
[PMID:22087237]
18. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De Jager PL, Gourraud PA, Cree BC et al.. (2010) Multiple sclerosis susceptibility alleles in African Americans.
Genes Immun, 11 (4): 343-50.
[PMID:19865102]
19. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. (2004) Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system.
Brain Res Mol Brain Res, 122 (1): 24-34.
[PMID:14992813]
20. Moratz C, Harrison K, Kehrl JH. (2004) Regulation of chemokine-induced lymphocyte migration by RGS proteins.
Meth Enzymol, 389: 15-32.
[PMID:15313557]
21. Moratz C, Hayman JR, Gu H, Kehrl JH. (2004) Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.
Mol Cell Biol, 24 (13): 5767-75.
[PMID:15199133]
22. Moratz C, Kang VH, Druey KM, Shi CS, Scheschonka A, Murphy PM, Kozasa T, Kehrl JH. (2000) Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes.
J Immunol, 164 (4): 1829-38.
[PMID:10657631]
23. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J et al.. (2013) Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
PLoS ONE, 8 (10): e75416.
[PMID:24130709]
24. Murphy JJ, Norton JD. (1993) Multiple signaling pathways mediate anti-Ig and IL-4-induced early response gene expression in human tonsillar B cells.
Eur J Immunol, 23 (11): 2876-81.
[PMID:7693480]
25. Nagata Y, Oda M, Nakata H, Shozaki Y, Kozasa T, Todokoro K. (2001) A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes.
Blood, 97 (10): 3051-60.
[PMID:11342430]
26. Newton JS, Deed RW, Mitchell EL, Murphy JJ, Norton JD. (1993) A B cell specific immediate early human gene is located on chromosome band 1q31 and encodes an alpha helical basic phosphoprotein.
Biochim Biophys Acta, 1216 (2): 314-6.
[PMID:8241276]
27. Pak HK, Gil M, Lee Y, Lee H, Lee AN, Roh J, Park CS. (2015) Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts.
PLoS ONE, 10 (4): e0124793.
[PMID:25897806]
28. Patel J, Channon KM, McNeill E. (2013) The downstream regulation of chemokine receptor signalling: implications for atherosclerosis.
Mediators Inflamm, 2013: 459520.
[PMID:23690662]
29. Patel J, Chuaiphichai S, Douglas G, Gorvin CM, Channon KM. (2018) Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control.
Vascul Pharmacol, 108: 15-22.
[PMID:29654907]
30. Patel J, McNeill E, Douglas G, Hale AB, de Bono J, Lee R, Iqbal AJ, Regan-Komito D, Stylianou E, Greaves DR et al.. (2015) RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.
Nat Commun, 6: 6614.
[PMID:25782711]
31. Plaza-Izurieta L, Castellanos-Rubio A, Irastorza I, Fernández-Jimenez N, Gutierrez G, CEGEC, Bilbao JR. (2011) Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes.
J Med Genet, 48 (7): 493-6.
[PMID:21490378]
32. Popov SG, Krishna UM, Falck JR, Wilkie TM. (2000) Ca2+/Calmodulin reverses phosphatidylinositol 3,4, 5-trisphosphate-dependent inhibition of regulators of G protein-signaling GTPase-activating protein activity.
J Biol Chem, 275 (25): 18962-8.
[PMID:10747990]
33. Reif K, Cyster JG. (2000) RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines.
J Immunol, 164 (9): 4720-9.
[PMID:10779778]
34. Roh J, Shin SJ, Lee AN, Yoon DH, Suh C, Park CJ, Huh J, Park CS. (2017) RGS1 expression is associated with poor prognosis in multiple myeloma.
J Clin Pathol, 70 (3): 202-207.
[PMID:27445341]
35. Romanos J, Barisani D, Trynka G, Zhernakova A, Bardella MT, Wijmenga C. (2009) Six new coeliac disease loci replicated in an Italian population confirm association with coeliac disease.
J Med Genet, 46 (1): 60-3.
[PMID:18805825]
36. Shi GX, Harrison K, Han SB, Moratz C, Kehrl JH. (2004) Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling.
J Immunol, 172 (9): 5175-84.
[PMID:15100254]
37. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C et al.. (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease.
N Engl J Med, 359 (26): 2767-77.
[PMID:19073967]
38. Soundararajan M, Willard FS, Kimple AJ, Turnbull AP, Ball LJ, Schoch GA, Gileadi C, Fedorov OY, Dowler EF, Higman VA et al.. (2008) Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.
Proc Natl Acad Sci USA, 105 (17): 6457-62.
[PMID:18434541]
39. Sun MY, Wang Y, Zhu J, Lv C, Wu K, Wang XW, Xue CY. (2018) Critical role for non‑GAP function of Gαs in RGS1‑mediated promotion of melanoma progression through AKT and ERK phosphorylation.
Oncol Rep, 39 (6): 2673-2680.
[PMID:29620236]
40. Tran T, Paz P, Velichko S, Cifrese J, Belur P, Yamaguchi KD, Ku K, Mirshahpanah P, Reder AT, Croze E. (2010) Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling.
Int J Cell Biol, 2010: 529376.
[PMID:21274427]
41. Willars GB. (2006) Mammalian RGS proteins: multifunctional regulators of cellular signalling.
Semin Cell Dev Biol, 17 (3): 363-76.
[PMID:16687250]